Učitavanje...
Duration of dual antiplatelet therapy in acute coronary syndrome
Despite a large volume of evidence supporting the use of dual antiplatelet therapy in patients with acute coronary syndrome, there remains major uncertainty regarding the optimal duration of therapy. Clinical trials have varied markedly in the duration of therapy, both across and within trials. Rece...
Spremljeno u:
| Izdano u: | Heart |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Heart
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5529971/ https://ncbi.nlm.nih.gov/pubmed/28249994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2016-309871 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|